Oral Guanabenz for Multiple Sclerosis

NCT02423083 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

NIH

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis

Interventions

DRUG: Guanabenz

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)